{"id":"W3163768133","doi":"10.1021/acsmedchemlett.1c00127","title":"Leveraging Open Science Drug Development for PET: Preliminary Neuroimaging of <sup>11</sup>C-Labeled ALK2 Inhibitors","year":2021,"lang":"en","type":"article","venue":"ACS Medicinal Chemistry Letters","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research; Centre for Addiction and Mental Health","funders":"Azrieli Foundation; Canada Research Chairs; Ontario Institute for Cancer Research; Canada Foundation for Innovation; Ontario Research Foundation","keywords":"Neuroimaging; Positron emission tomography; Pons; Drug discovery; Radioligand; Medicine; Pet imaging; Activin receptor; Pharmacology; Neuroscience; Nuclear medicine; Bioinformatics; Receptor; Psychology; Internal medicine; Biology; Psychiatry","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["open_science"],"consensus_categories":[],"category_scores_codex":[0.0002816154,0.0004854873,0.0002479569,0.0001668081,0.0001820744,0.0004377066,0.0002612309,0.0005980964,0.002029056],"category_scores_gemma":[0.0003149408,0.0001787252,0.0001623774,0.0001672925,0.0003216745,0.0004401332,0.0001897641,0.0006225431,0.0005571024],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002715611,"about_ca_system_score_gemma":0.0003563168,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00177278,"about_ca_topic_score_gemma":0.002880677,"domain_scores_codex":[0.9999222,0.00001731789,0.00000277531,0.00001341766,0.00001402314,0.00003027413],"domain_scores_gemma":[0.9999061,0.00002852363,0.00001766397,0.00001217139,0.0000177443,0.00001777716],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0005361388,0.000112534,0.0005798608,0.0001500871,0.00002517599,0.000641602,0.00003555958,0.000549109,0.9810868,0.0006822767,0.0009392294,0.01466164],"study_design_scores_gemma":[0.00006133336,0.001555419,0.002622111,0.00001396234,0.00005071276,0.001720939,0.00002997139,0.002269099,0.9791899,0.0003327199,0.01213585,0.00001801695],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8879858,0.0109333,0.05882866,0.001956682,0.0002105311,0.0006033512,0.001667306,0.0006611487,0.03715324],"genre_scores_gemma":[0.9684461,0.003256146,0.02014911,0.00047211,0.00002848301,0.0001675458,0.001206915,0.0001124472,0.006161259],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9997388,"threshold_uncertainty_score":0.006787896,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02006528451640505,"score_gpt":0.2771546613823037,"score_spread":0.2570893768658987,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}